Abstract:Background and aims: Peroxisome proliferator-activated receptor alpha (PPARa) regulates expression of multiple genes involving lipid metabolism, bile acids (BA) homeostasis, and shows protective effects against inflammation and apoptosis.Progressive diseases such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) result in intrahepatic retention of toxic BA that may lead to liver dysfunction and failure.Small non-coding RNA molecules (miRNAs) regulate gene expression, and miR-155 was associated with silencing of PPARa.Since PPARa activation decreases inflammation and fibrosis we evaluated PPARa and miR-155 expressions in cholestatic livers.We have also analyzed the regulatory effect of miR-155 on PPARa expression in vitro.Method: Liver samples were taken from biopsies at early stages (F1-F2) of PBC (n = 12) or from explanted livers in patients with cirrhotic PBC (n = 11) and PSC (n = 17).The functional role of miR-155 was characterized in vitro in hepatocytes (HepG2) and primary cholangiocytes (NHC) where overexpression of miR-155 was induced by mirVana miRNA Mimic.miR-155 expression levels were evaluated after treatment with lipopolysaccharide (LPS), glycodeoxycholic acid (GCDCA), lithocholic acid (LCA) or ursodeoxycholic acid (UDCA).Results: When compared to controls hepatic PPARa mRNA and protein levels were reduced in cirrhotic PBC (both 50% reduction, P = 0.01), but not in PSC livers.In PBC livers this phenomenon was accompanied with induction of miR-155 (3.7-fold increase, P = 0.004 vs. control).Experimental overexpression of miR-155 in HepG2 led to the inhibition of PPARa (50% reduction, P = 0.02).LPS stimulated miR-155 expression in HepG2 (over 40-fold increase, p = 0.009), whereas the treatment with GCDCA or LCA enhanced the expression of miR-155 in NHC (2-fold p < 0.05, or 2.4 fold p < 0.05, respectively).UDCA suppressed the basal expression of miR-155 in NHC (20% reduction, p = 0.02 vs. control) as well as the LPS-induced miR-155 in HepG2 ( p = 0.009 vs LPS). Conclusion:We showed that PPARa is substantially reduced in PBC livers, and the observed concomitant overexpression of miR-155 induced either by inflammation or bile acids may be accountable for this suppression.Inhibition of miR-155 may be a potential novel therapeutic target in PBC.

Rbpj deletion in hepatic progenitor cells attenuates endothelial responses in a mouse model of cholestatic liver disease

Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy

Notch-Rbp-J Signaling Regulates The Mobilization And Function Of Endothelial Progenitor Cells By Dynamic Modulation Of Cxcr4 Expression In Mice

Disruption of the transcription factor recombination signal-binding protein-Jkappa (RBP-J) leads to veno-occlusive disease and interfered liver regeneration in mice.

Dual Deletion of Keap1 and Rbpjκ Genes in Liver Leads to Hepatomegaly and Hypercholesterolemia

PPARα Regulates Mobilization and Homing of Endothelial Progenitor Cells Through the HIF-1α/SDF-1 Pathway

Rbpj, the Transcription Factor Downstream of Notch Receptors, is Essential for the Maintenance of Vascular Homeostasis in Adult Mice

Hepatic progenitor cell-originated ductular reaction facilitates liver fibrosis through activation of hedgehog signaling

Myeloid-specific disruption of recombination signal binding protein Jκ ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice.

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma

Differential Regulation of Bone Marrow-Derived Endothelial Progenitor Cells and Endothelial Outgrowth Cells by the Notch Signaling Pathway.

Hepatopoietin Cn Reduces Ethanol-Induced Hepatoxicity Via Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptors.

Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice

Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulation

P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases

Bone Morphogenetic Protein 9 As a Key Regulator of Liver Progenitor Cells in DDC‐induced Cholestatic Liver Injury

The suppression of pancreatic lipase-related protein 2 ameliorates experimental hepatic fibrosis in mice

Cholangiocytes-Specific Deletion of Sphingosine-1-phospholipid Receptor 1 Attenuate Cholestasis Induced Liver Injury and Fibrosis

(Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice from Diet-Induced Obesity and Hepatosteatosis

PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury

A pivotal role of BEX1 in liver progenitor cell expansion in mice